Cipla Limited — Important, 03-02-2025: General Updates

Cipla Ltd. will invest approximately ZAR 900 million in equity share capital of its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Limited (CMSA). This investment aims to reduce inter-group debt and enhance the capital structure of CMSA and its subsidiaries. The acquisition, which falls under a related party transaction and will be conducted at arm's length, involves the purchase of 40,742,417 equity shares at a total cost of ZAR 899,999,992. CMSA, incorporated on July 15, 2013, has demonstrated varied financial performance, with reported turnovers of ZAR 688.28 million for FY 2023-24, ZAR 1.12 billion for FY 2022-23, and ZAR 1.71 billion for FY 2021-22. The transaction is expected to be finalized by February 28, 2025, positioning Cipla to strengthen its operations in the South African market.